Glycopeptide resistance in Staphylococcus aureus: is it a real threat?
- 1 January 2004
- journal article
- review article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 10 (2) , 69-75
- https://doi.org/10.1007/s10156-004-0307-5
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Vancomycin-Resistant Staphylococcus aureus Isolate from a Patient in PennsylvaniaAntimicrobial Agents and Chemotherapy, 2004
- Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical CenterJournal of Antimicrobial Chemotherapy, 2003
- Infection with Vancomycin-ResistantStaphylococcus aureusContaining thevanAResistance GeneNew England Journal of Medicine, 2003
- Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterizationDiagnostic Microbiology and Infectious Disease, 2003
- Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical featuresJournal of Antimicrobial Chemotherapy, 2002
- Clinical Isolate of Vancomycin-Heterointermediate Staphylococcus aureus Susceptible to Methicillin and In Vitro Selection of a Vancomycin-Resistant DerivativeAntimicrobial Agents and Chemotherapy, 2001
- Emergence of heterogeneous intermediate vancomycin resistance in Staphylococcus aureus isolates in the Dusseldorf areaJournal of Antimicrobial Chemotherapy, 1999
- The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in JapanThe American Journal of Medicine, 1998
- First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospitalThe Lancet, 1998
- Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycinThe Lancet, 1997